经耻骨后尿道中段悬吊带术治疗女性复发性压力性尿失禁的中长期疗效

doi:10.19723/j.issn.1671-167X.2024.04.009

摘要/Abstract

摘要：

目的: 探讨经耻骨后尿道中段悬吊带术(tension-free vaginal tape，TVT)治疗女性复发性压力性尿失禁(recurrent stress urinary incontinence，rSUI)的效果及临床疗效。方法: 回顾性分析2016年1月至2020年6月于北京朝阳医院采用TVT治疗rSUI的患者，收集患者基本信息。使用国际尿失禁咨询委员会尿失禁问卷表简表(International Consultation on Incontinence questionnaire-short form，ICI-Q-SF)记录患者术前、术后1年、术后3年以上的尿失禁症状评分，比较ICI-Q-SF各项评分及总分变化, 同时记录并比较患者术前、术后3年以上的尿失禁临床症状严重程度。结果: 共纳入24例患者，其中1例在术后1年因脑血管意外死亡，余23例随访时间3.9~7.3年，平均随访时间(5.2±1.1)年。ICI-Q-SF总分中位数术前为20.0(16.0，21.0)，术后1年及平均5年随访时为5.0(1.5，7.8)和6.0(3.0，9.0)，与术前比较差异均有统计学意义(P < 0.001)；ICI-Q-SF各分项评分在术后1年及平均5年的随访中均较术前减低，差异具有统计学意义(P < 0.001)。从尿失禁严重程度来看，术前所有患者表现为中-重度尿失禁；术后平均5年，87.0%(20/23)的患者无尿失禁或仅有轻度尿失禁，13.0%(3/23)的患者再次出现中-重度尿失禁(P < 0.001)。结论: TVT对女性rSUI治疗有效，平均5年治愈和有效改善率达到87.0%。

关键词: 压力性尿失禁, 女性, 复发, 尿道下悬吊术

Abstract:

Objective: To investigate the effectiveness and clinical efficacy of tension-free vaginal tape (TVT) surgery in treating female recurrent stress urinary incontinence (rSUI). Methods: A retrospective analysis was conducted on 24 patients who experienced recurrence of mid-urethral sling failure and were treated with TVT surgery at Beijing Chao-Yang Hospital from January 2016 to June 2020. Basic patient information was collected. The International Consultation on Incontinence questionnaire-short form (ICI-Q-SF) was used to record urinary incontinence symptom scores preoperatively, 1-year postoperatively, and more than three years postoperatively. The changes in various ICI-Q-SF scores and total scores were compared. Additionally, clinical symptom severity of urinary incontinence was recorded and compared preoperatively and more than three years postoperatively. Results: Among the 24 patients included in the follow-up, one patient was lost to follow-up due to death from a cerebrovascular accident one year postoperatively, leaving 23 patients with a follow-up period ranging from 3.9 to 7.3 years, with an ave-rage follow-up time of (5.2±1.1) years. Preoperatively, the median ICI-Q-SF total score was 20.0 (16.0, 21.0); at the 1-year follow-up, the median ICI-Q-SF total score was 5.0 (1.5, 7.8) (P < 0.001); at an average follow-up of five years, the median ICI-Q-SF total score was 6.0 (3.0, 9.0), still showing a statistically significant difference compared with preoperative scores (P < 0.001). The individual ICI-Q-SF scores were significantly lower at the 1-year and average five-year follow-ups compared with preoperative scores (P < 0.001). Regarding the severity of urinary incontinence, all the patients had moderate to severe urinary incontinence preoperatively; Five years postoperatively, 87.0% (20/23) of the patients had no or only mild urinary incontinence, and 13.0% (3/23) had recurrent moderate to severe urinary incontinence (P < 0.001). Conclusion: TVT surgery is effective in treating female recurrent stress urinary incontinence, with an average 5-year cure and improvement rate of 87.0%.

Key words: Stress urinary incontinence, Female, Recurrence, Suburethral slings

中图分类号:

R694.54

李雨清,王飚,乔鹏,王玮,关星. 经耻骨后尿道中段悬吊带术治疗女性复发性压力性尿失禁的中长期疗效[J]. 北京大学学报（医学版）, 2024, 56(4): 600-604.

Yuqing LI,Biao WANG,Peng QIAO,Wei WANG,Xing GUAN. Medium to long-term efficacy of tension-free vaginal tape procedure in the treatment of female recurrent stress urinary incontinence[J]. Journal of Peking University (Health Sciences), 2024, 56(4): 600-604.

图/表 2

表1

表2

参考文献 16

1	杨琳. 三甲综合医院妇科门诊成年女性盆底功能障碍疾病相关症状问卷调查[D]. 太原: 山西医科大学, 2021.
2	杨琳, 姚跟心, 吴素慧. 1 232例妇科门诊中老年女性盆底功能障碍性疾病状况调查[J]. 中国计划生育和妇产科, 2021, 13 (8): 35- 38. doi: 10.3969/j.issn.1674-4020.2021.08.10
3	中华医学会妇产科学分会妇科盆底学组. 女性压力性尿失禁诊断和治疗指南(2017)[J]. 中华妇产科杂志, 2017, 52 (5): 289- 293. doi: 10.3760/cma.j.issn.0529-567x.2017.05.001
4	Jun T , Yoon HS , Kim HS , et al. Recurrence rate of stress urinary incontinence in females with initial cure after transobturator tape procedure at 3-year follow-up[J]. Investig Clin Urol, 2017, 58 (1): 54- 60. doi: 10.4111/icu.2017.58.1.54
5	Braga A , Caccia G , Papadia A , et al. Urethral bulking agents for the treatment of recurrent stress urinary incontinence: A systematic review and meta-analysis[J]. Maturitas, 2022, 163, 28- 37. doi: 10.1016/j.maturitas.2022.05.007
6	Agur W , Pope C , Greenwell T , et al. Treating women with recurrent stress urinary incontinence: A hornet's nest still needing proper clinical evidence[J]. Eur Urol, 2021, 79 (1): 6- 7. doi: 10.1016/j.eururo.2020.10.030
7	Maclachlan LS , Rovner ES . Management of failed stress urinary incontinence surgery[J]. Curr Urol Rep, 2014, 15 (8): 429. doi: 10.1007/s11934-014-0429-y
8	Serati M , Giammo A , Carone R , et al. Bulking agents for the treatment of recurrent stress urinary incontinence: A suitable option?[J]. Minerva Urol Nephrol, 2022, 74 (6): 747- 754.
9	Barakat B , Franke K , Hijazi S , et al. A systematic review and meta-analysis of clinical and functional outcomes of artificial urinary sphincter implantation in women with stress urinary incontinence[J]. Arab J Urol, 2020, 18 (2): 78- 87. doi: 10.1080/2090598X.2020.1716293
10	Reus CR , Phe V , Dechartres A , et al. Performance and safety of the artificial urinary sphincter (AMS 800) for non-neurogenic women with urinary incontinence secondary to intrinsic sphincter deficiency: A systematic review[J]. Eur Urol Focus, 2020, 6 (2): 327- 338. doi: 10.1016/j.euf.2018.10.009
11	Peyronnet B , O'connor E , Khavari R , et al. AMS-800 artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review[J]. Neurourol Urodyn, 2019, 38 (Suppl 4): S28- S41.
12	Nikolopoulos KI , Betschart C , Doumouchtsis SK . The surgical management of recurrent stress urinary incontinence: A systematic review[J]. Acta Obstet Gynecol Scand, 2015, 94 (6): 568- 576. doi: 10.1111/aogs.12625
13	张耀光, 万奔, 魏东, 等. 经耻骨后无张力尿道悬吊术治疗女性复发性压力性尿失禁的临床分析[J]. 中华泌尿外科杂志, 2016, 37 (12): 888- 891. doi: 10.3760/cma.j.issn.1000-6702.2016.12.003
14	夏红, 李怀芳, 童晓文, 等. 女性压力性尿失禁经阴道尿道中段悬吊术后症状持续或复发的补救手术[J]. 中华泌尿外科杂志, 2013, 34 (7): 533- 537. doi: 10.3760/cma.j.issn.1000-6702.2013.07.017
15	姜兴金, 杨明州, 万刚, 等. 原尿道中段悬吊带缩紧术治疗复发性女性压力性尿失禁(附3例报告)[J]. 中国保健营养, 2017, 27 (16): 390- 391.
16	Appell RA , Davila GW . Treatment options for patients with suboptimal response to surgery for stress urinary incontinence[J]. Curr Med Res Opin, 2007, 23 (2): 285- 292. doi: 10.1185/030079906X162845

相关文章 15

[1]	姚中强,李常虹,李欣艺,郭苇,翟佳羽,刘蕊,魏慧,穆荣. 抗磷脂酰丝氨酸/凝血酶原抗体与不明原因复发性流产的相关性分析[J]. 北京大学学报（医学版）, 2023, 55(6): 1058-1061.
[2]	王子恺,莫佳丽,张蒙,廖纪萍. 2013—2020年北京市慢性阻塞性肺疾病急性加重女性住院患者的流行病学和住院费用分析[J]. 北京大学学报（医学版）, 2023, 55(6): 1074-1081.
[3]	姬学朝,刘珊,王万州,赵烨彤,李陆一,张文楼,沈国锋,邓芙蓉,郭新彪. 室内挥发性有机物与年轻女性夜间心率变异性关联的定组研究[J]. 北京大学学报（医学版）, 2023, 55(3): 488-494.
[4]	孙希雅,陈艺璐,曾琳,闫丽盈,乔杰,李蓉,智旭. 不孕女性维生素D水平与抗苗勒氏管激素的相关性及对妊娠结局的预测[J]. 北京大学学报（医学版）, 2023, 55(1): 167-173.
[5]	陈素华,杨军,陈新,杨辰龙,孙建军,林国中,于涛,杨欣,韩芸峰,吴超,司雨,马凯明. 大型、巨大型上矢状窦中后1/3侵犯颅外复发脑膜瘤的手术治疗[J]. 北京大学学报（医学版）, 2022, 54(5): 1006-1012.
[6]	方伟岗,田新霞,解云涛. 基因多态性对中国汉族女性乳腺癌遗传易感性的影响[J]. 北京大学学报（医学版）, 2022, 54(5): 822-828.
[7]	王跃,张爽,张虹,梁丽,徐玲,程元甲,段学宁,刘荫华,李挺. 激素受体阳性/人表皮生长因子受体2阴性乳腺癌临床病理特征及预后[J]. 北京大学学报（医学版）, 2022, 54(5): 853-862.
[8]	森本智惠子,王益勤,周蓉,王建六. 子宫内膜非典型增生及子宫内膜癌患者保留生育功能治疗的临床研究[J]. 北京大学学报（医学版）, 2022, 54(5): 936-942.
[9]	刘磊,秦艳春,王国良,张树栋,侯小飞,马潞林. 嗜铬细胞瘤和副神经节瘤二次手术策略[J]. 北京大学学报（医学版）, 2021, 53(4): 793-797.
[10]	于焕斌,伍文杰,吕晓鸣,石妍,郑磊,张建国. ¹²⁵I粒子近距离治疗外放疗后复发唾液腺癌[J]. 北京大学学报（医学版）, 2020, 52(5): 919-923.
[11]	熊盛炜,王杰,朱伟杰,程嗣达,张雷,李学松,周利群. 二次肾盂成形术在复发性肾盂输尿管连接部梗阻中的研究进展[J]. 北京大学学报（医学版）, 2020, 52(4): 794-798.
[12]	侯磊,叶国华,刘筱菁,李自力. 下颌后缩伴颞下颌关节重度骨关节病患者正颌术后颌骨稳定性及髁突体积变化的评价[J]. 北京大学学报（医学版）, 2020, 52(1): 113-118.
[13]	张晓鹏,张维宇,霍飞,胡浩,王起,许克新. 原发性女性膀胱出口梗阻的手术疗效随访及其发病机制[J]. 北京大学学报（医学版）, 2019, 51(6): 1052-1055.
[14]	张旭初,张建华,王荣福,范岩,付占立,闫平,赵光宇,白艳霞. ¹⁸F-FDG PET/CT联合多种肿瘤标志物在结直肠中分化腺癌术后复发及转移中的应用价值[J]. 北京大学学报（医学版）, 2019, 51(6): 1071-1077.
[15]	张维宇,夏秋翔,胡浩,陈京文,孙屹然,许克新,张晓鹏. 门诊女性下尿路症状患者尿动力学检查结果分析及逼尿肌无力患者的随访[J]. 北京大学学报（医学版）, 2019, 51(5): 856-862.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Items	Preoperation	1 year postoperation	Average 5 years postoperation
Frequency of leakage	4.5 (4, 5)	1.0 (1.0, 2.0)^*	1 (1, 2)^*
Amount of leakage	6 (4, 6)	2.0 (0.5, 2.0)^*	2 (2, 2)^*
Overall impact of urinary incontinence	10 (8, 10)	2.0 (0.3, 3.0)^*	2 (1, 4)^*
Total ICI-Q-SF score	20 (16, 21)	5.0 (1.5, 7.8)^*	6 (3, 9)^*

Severity of clinical symptoms of SUI	Preoperative	Average 5 years postoperative
Never	0	11 (47.8)
Mild	0	9 (39.1)
Moderate	21 (87.5)	2 (8.7)
Sever	3 (12.5)	1 (4.3)
P^*	< 0.001	< 0.001